---
title: "Zepbound Appetite & Cravings Changes: The Evidence"
description: "The Zepbound label says tirzepatide lowers calorie intake, likely through appetite. Cravings by food type are not reported. Nausea covered."
url: https://healthrx.com/zepbound-v2/appetite-cravings-changes
publisher: HealthRX.com
---


HealthRX.com

Zepbound lowers intake; specific craving changes are not documented

[Print or save as PDF](https://healthrx.com/printables/zepbound-v2/appetite-cravings-changes?print=1)

Key numbers

- -3.1% Mean weight change at week 72 on placebo in SURMOUNT-1 adults Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35658024/), as cited Nov 7, 2026
- 56.7% Share losing 20% or more of body weight on 15 mg tirzepatide in SURMOUNT-1, versus 3.1% on placebo Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35658024/), as cited Nov 7, 2026
- -5.5% Weight change from week 36 to 88 on continued tirzepatide in SURMOUNT-4 Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/38078870/), as cited Nov 7, 2026

[See the public record for Tirzepatide](https://healthrx.com/data/tirzepatide)

HealthRX.com quick answer. Zepbound (tirzepatide) lowers appetite and food intake: the label states that tirzepatide decreases calorie intake and that this effect is likely mediated by affecting appetite [1]. In SURMOUNT-1, adults with obesity but no diabetes lost a mean 20.9% of body weight over 72 weeks on 15 mg weekly, 19.5% on 10 mg and 15.0% on 5 mg, against 3.1% on placebo [2]. A food-specific change in cravings, such as sweets and fried food fading while protein stays appealing, is not reported in the label or in the SURMOUNT trial results.

At a glance

- Drug class / Dual GIP and GLP-1 receptor agonist, once-weekly subcutaneous injection [1]
- Label on intake / Decreases calorie intake, likely by affecting appetite [1]
- Weight change at 72 weeks / -20.9% (15 mg), -19.5% (10 mg), -15.0% (5 mg) vs -3.1% placebo in SURMOUNT-1 [2]
- Craving data by food type / Not reported in the label or SURMOUNT results
- Stomach emptying / Delayed; largest after the first dose and diminishes over time [1]
- Nausea at 15 mg / 28% vs 8% on placebo; most nausea, vomiting and diarrhea occurred during dose escalation [1]
- After stopping / Weight change week 36 to 88: -5.5% continuing vs +14.0% switched to placebo [3]

## Does Zepbound actually reduce appetite?

Yes, and the effect is written into the label. The Zepbound prescribing information states that tirzepatide decreases calorie intake and that the effect is likely mediated by affecting appetite [1]. Tirzepatide activates both the GIP receptor and the GLP-1 receptor and is injected subcutaneously once a week [1].

The [Mounjaro](https://healthrx.com/mounjaro) label (the [type 2 diabetes](https://healthrx.com/conditions-type-2-diabetes/diagnosis-algorithm) product containing tirzepatide) also lists decreased appetite as an adverse reaction in its pooled placebo-controlled trials (SURPASS-1 and SURPASS-5): 5% on 5 mg, 10% on 10 mg and 11% on 15 mg, versus 1% on placebo. Those trials enrolled adults with type 2 diabetes rather than obesity alone, and the label says adverse reaction rates from different trials cannot be compared directly.

## What the weight trials measured

SURMOUNT-1 randomized 2,539 adults with a BMI of 30 or more, or 27 or more with at least one weight-related complication, and without diabetes, to 5, 10 or 15 mg of tirzepatide or placebo for 72 weeks [2]. Its coprimary endpoints were the percentage change in weight and the proportion of participants losing at least 5% [2].

Mean weight change at week 72 was -15.0% on 5 mg, -19.5% on 10 mg and -20.9% on 15 mg, against -3.1% on placebo [2]. Weight loss of 20% or more occurred in 30.0% of the 5 mg group, 50.1% of the 10 mg group and 56.7% of the 15 mg group, against 3.1% on placebo [1][2].

Weight is the outcome the trial was built to measure. The statement that [tirzepatide](https://healthrx.com/products/tirzepatide) lowers calorie intake through appetite comes from the label's description of how the drug works [1].

## Do specific cravings change, or just overall hunger?

The label and the SURMOUNT results report overall calorie intake and weight, not cravings by food category such as sweets, fried food or protein [1][2]. So the widely repeated idea that Zepbound specifically removes a sweet tooth or a fast-food habit is not a documented finding. What is documented is a reduction in calorie intake, attributed to appetite, and large mean weight reductions.

What people on Reddit report

Accounts from r/Zepbound users about whether cravings or hunger changed on Zepbound, with mixed reports on specific food cravings versus general hunger.

EVChicinNJ · Zepbound

I don't find that Zepbound does anything meaningful regarding cravings or food volume. However, as long as I prioritize protein & fiber, my cravings are pretty non existent.

Reports that Zepbound did not meaningfully change cravings or food volume, and that keeping protein and fiber high kept cravings low.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1up8g4n/at_what_dose_did_you_notice_a_reduction_in/)

Elsa-the-Brave · Zepbound

Before Zepbound I almost always craved sweet foods. I've noticed recently that when I do get cravings, it's been for protein, like shrimp or meat or beans.

Reports that sweet cravings were replaced by cravings for protein foods such as meat, shrimp or beans after starting the drug.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1pjp6wc/food_cravings_have_changed/)

laureninboston · Zepbound

Yup. It feels totally random. One day I'll be super hungry and the next day back to reduced appetite.

Reports hunger that comes and goes at random from one day to the next, with reduced appetite on other days.

[Read the source discussion](https://www.reddit.com/r/Zepbound/comments/1c0lho8/anyone_else_just_have_random_hungry_days/)

Questions worth asking

Choose the questions you want to keep Can cravings for specific foods change on Zepbound, or is the change mainly overall hunger? Which weight and calorie intake changes on Zepbound has the label actually documented? Should I track cravings and hunger by food type during the first months on Zepbound? How should I plan meals if my appetite drops suddenly while on Zepbound? Which nausea patterns should I report to my prescriber during a Zepbound dose increase? Does the label say whether appetite changes continue after stopping Zepbound?

Beyond the Scale host on food noise, cravings and the addiction research

The host argues that food noise is a real but personal experience: persistent thoughts about food that differ from physical hunger. They say some people on these medications notice those thoughts quieting down while others notice much less change. They present the addiction research as interesting but early, pointing to animal studies and a small trial, and say these medications are not approved for addiction and should not replace established treatment. The host also believes weight struggles should not be read as personal failure, because appetite is shaped by hormones, environment and reward pathways. Medications do not resolve every emotional or behavioral issue, so nutrition, habits and support still matter.

Who is speaking?

Beyond the Scale: My GLP-1 Journey. Host of the channel Beyond the Scale: My GLP-1 Journey, as described on the channel [Background](https://www.youtube.com/watch?v=f6r7CHraKxc)

[Episode notes and full video](https://www.youtube.com/watch?v=f6r7CHraKxc)

## Does Zepbound slow stomach emptying?

The label states that tirzepatide delays gastric emptying, that the delay is largest after the first dose and that it diminishes over time [1].

## Nausea and dose escalation

Zepbound starts at 2.5 mg once weekly for 4 weeks; 2.5 mg is an initiation dose and is not approved as a maintenance dose. The dose then goes to 5 mg, and can rise in 2.5 mg steps after at least 4 weeks at the current dose, to maintenance doses of 5, 10 or 15 mg weekly [1]. The label says that if a maintenance dose is not tolerated, a lower maintenance dose should be considered [1].

In the pooled Zepbound weight trials (SURMOUNT-1 and SURMOUNT-2, up to 72 weeks), nausea occurred in 25% of patients on 5 mg, 29% on 10 mg and 28% on 15 mg, versus 8% on placebo; vomiting occurred in 8%, 11% and 13%, versus 2% [1]. Any gastrointestinal adverse reaction was reported by 56% at every Zepbound dose, versus 30% on placebo, and most nausea, vomiting and diarrhea occurred during dose escalation and decreased over time [1]. Severe gastrointestinal reactions were reported by 1.7%, 2.5% and 3.1% of the 5, 10 and 15 mg groups, versus 1% on placebo [1].

The label also warns about acute kidney injury from volume depletion, noting that most reported cases occurred in patients with gastrointestinal reactions leading to dehydration, and states that Zepbound is not recommended in patients with severe gastroparesis [1].

## Does the effect last after stopping?

SURMOUNT-4 addresses the weight question directly. 783 adults received open-label tirzepatide at the maximum tolerated dose (10 or 15 mg) for 36 weeks; the 670 who were then randomized had lost a mean 20.9% of body weight. They continued tirzepatide or switched to placebo. From week 36 to week 88, weight changed -5.5% on continued tirzepatide versus +14.0% after switching to placebo [3]. Stopping the drug led to substantial weight regain. This measured weight, not appetite.

## Is tirzepatide stronger than semaglutide for appetite?

SURMOUNT-5 was an open-label trial of 751 adults with obesity and no type 2 diabetes, comparing maximum tolerated tirzepatide (10 or 15 mg) with maximum tolerated semaglutide (1.7 or 2.4 mg) for 72 weeks. Mean weight change was -20.2% with tirzepatide and -13.7% with semaglutide [4]. That is a weight outcome. It does not measure craving, so it cannot show that tirzepatide controls cravings better.

## Does a smaller appetite mean losing muscle?

Body composition was measured in a substudy of SURMOUNT-1: 160 participants had DXA scans at baseline and week 72. Body weight fell 21.3%, fat mass 33.9% and lean mass 10.9% with tirzepatide, versus 5.3%, 8.2% and 2.6% with placebo. About 75% of the weight lost was fat mass and about 25% lean mass, the same proportion seen with placebo [5]. The substudy was small, and DXA does not separate muscle from other lean tissue. The label states that tirzepatide lowers body weight with greater fat mass loss than lean mass loss [1][5].

## Zepbound and compounded tirzepatide

HealthRX.com offers [compounded tirzepatide](https://healthrx.com/products/tirzepatide) by prescription. Compounded drugs are not FDA approved and are not reviewed for safety, effectiveness or quality before they are marketed [6].

Printable symptom log

Zepbound appetite and cravings tracking sheet

Use this sheet to track appetite, food cravings, nausea and dose changes while taking Zepbound. Fill it in by hand, then bring it to your prescriber or pharmacist, or keep it at home for reference.

[Open the fill-in sheet](https://healthrx.com/printables/zepbound-v2/appetite-cravings-changes) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

How quickly does Zepbound change appetite?

The label does not describe a timeline for appetite change. It reports that tirzepatide reaches peak concentration a median of 24 hours after an injection and reaches steady state after 4 weeks of weekly dosing, and that the gastric-emptying delay is largest after the first dose [1]. Dosing starts at 2.5 mg weekly for 4 weeks as an initiation dose, then 5 mg, with 2.5 mg steps no sooner than every 4 weeks to a maintenance dose of 5, 10 or 15 mg [1].

Does Zepbound reduce cravings for specific foods?

Cravings by food category are not reported in the label or the SURMOUNT results. What is documented is a fall in calorie intake attributed to appetite [1] and large mean weight reductions versus placebo, from 15.0% at 5 mg to 20.9% at 15 mg over 72 weeks [2].

Is the appetite suppression just nausea?

Nausea is common and dose-related, affecting 25% to 29% of Zepbound-treated patients versus 8% on placebo, with most nausea, vomiting and diarrhea during dose escalation and decreasing over time [1]. The label states that the decrease in calorie intake is likely mediated by affecting appetite [1].

Does the effect go away when Zepbound is stopped?

In SURMOUNT-4, weight changed -5.5% from week 36 to week 88 in people who kept taking tirzepatide, versus +14.0% in those switched to placebo [3]. That is a weight finding, not a direct measurement of appetite after stopping.

Is tirzepatide better than semaglutide for appetite?

Head-to-head, tirzepatide produced a mean weight change of -20.2% versus -13.7% with semaglutide over 72 weeks in 751 adults with obesity [4]. That comparison measured weight, not cravings, so it does not answer the craving question.

Will I lose muscle on Zepbound?

In a 160-person body-composition substudy of SURMOUNT-1, about 75% of the weight lost on tirzepatide was fat mass and about 25% was lean mass, the same split as placebo, and the label states that fat mass loss exceeds lean mass loss [1][5].

## Quick summary of Zepbound and appetite evidence

Zepbound reduces how much people eat, and the label ties that to appetite [1]. The weight consequences are large and well measured: mean changes of -15.0% to -20.9% over 72 weeks depending on dose, versus -3.1% on placebo [2], with substantial regain over the 52 weeks after switching to placebo [3]. Whether specific cravings for sweets, fried food or protein change selectively is not reported in the label or the SURMOUNT results.

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

How to reduce appetite?

On Zepbound, the label states that tirzepatide decreases calorie intake and that this effect is likely mediated by affecting appetite. In SURMOUNT-1, mean weight change at week 72 was -15.0% on 5 mg, -19.5% on 10 mg and -20.9% on 15 mg, against -3.1% on placebo. Nausea is common, affecting 25% to 29% of patients on Zepbound doses, and most of it occurs during dose escalation.

What do hunger/cravings feel like on Zepbound?

Descriptions of how hunger or cravings feel are not reported in the label or the SURMOUNT results. What is documented is an overall reduction in calorie intake, which the label attributes to appetite, and large mean weight reductions. Changes in cravings for specific foods such as sweets, fried food or protein are not reported.

References

Show all 10 references Hide references

1. U.S. National Library of Medicine, DailyMed. Zepbound injection (tirzepatide) prescribing information. [Zepbound injection (tirzepatide) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
2. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. [Tirzepatide Once Weekly for the Treatment of Obesity](https://pubmed.ncbi.nlm.nih.gov/35658024/). N Engl J Med. 2022;387(3):205-216.
3. Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, et al. [Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial](https://pubmed.ncbi.nlm.nih.gov/38078870/). JAMA. 2024;331(1):38-48.
4. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, et al. [Tirzepatide as Compared with Semaglutide for the Treatment of Obesity](https://pubmed.ncbi.nlm.nih.gov/40353578/). N Engl J Med. 2025;393(1):26-36.
5. Look M, Dunn JP, Kushner RF, Cao D, Harris C, Gibble TH, et al. [Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight](https://pubmed.ncbi.nlm.nih.gov/39996356/). Diabetes Obes Metab. 2025;27(5):2720-2729.
6. [FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss | FDA](http://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss).
7. Reddit participants. [At what dose did you notice a reduction in cravings? (r/Zepbound)](https://www.reddit.com/r/Zepbound/comments/1up8g4n/at_what_dose_did_you_notice_a_reduction_in/). Accessed 2026-11-10.
8. Reddit participants. [Food cravings have changed… (r/Zepbound)](https://www.reddit.com/r/Zepbound/comments/1pjp6wc/food_cravings_have_changed/). Accessed 2026-11-10.
9. Reddit participants. [Anyone else just have random hungry days? (r/Zepbound)](https://www.reddit.com/r/Zepbound/comments/1c0lho8/anyone_else_just_have_random_hungry_days/). Accessed 2026-11-10.
10. Beyond the Scale: My GLP-1 Journey. [GLP-1 Food Noise Explained: How Ozempic & Zepbound May Affect Cravings and Addiction](https://www.youtube.com/watch?v=f6r7CHraKxc). Accessed 2026-11-11.

Next in this cluster

Related reading

- [tirzepatide Zepbound re-titration after stopping](https://healthrx.com/titration-zepbound/re-titration-after-stop)
- [tirzepatide How to stop Zepbound](https://healthrx.com/zepbound/discontinuation-protocol)
- [tirzepatide Zepbound for PCOS](https://healthrx.com/off-label-zepbound/pcos--risks-tradeoffs)
- [tirzepatide Zepbound missed dose](https://healthrx.com/zepbound/missed-dose-protocol)
- [tirzepatide Compounded tirzepatide](https://healthrx.com/access-zepbound/compounded-equivalent)
- [tirzepatide Zepbound HSA/FSA Eligibility and Submission](https://healthrx.com/access-zepbound/hsa-fsa-eligibility)
- [tirzepatide Zepbound Medicare Advantage coverage](https://healthrx.com/access-zepbound/medicare-advantage)
- [tirzepatide Zepbound Medicare Part D](https://healthrx.com/access-zepbound/medicare-part-d)
- [tirzepatide Zepbound patient assistance](https://healthrx.com/access-zepbound/patient-assistance)
- [tirzepatide Zepbound Geriatric (65+) Caregiver Administration Guidance](https://healthrx.com/age-v2-zepbound/geriatric--caregiver-administration)
- [tirzepatide Zepbound restarting after acute illness](https://healthrx.com/zepbound-v2/post-illness-restart)
- [tirzepatide Tirzepatide Pre-Surgery hold](https://healthrx.com/zepbound-v2/pre-surgery-window)
- [tirzepatide Does UnitedHealthcare cover Zepbound](https://healthrx.com/zepbound/unitedhealthcare-coverage)
- [zepbound vs rybelsus Zepbound vs Rybelsus Head-to-Head efficacy](https://healthrx.com/compare-glp-1/zepbound-vs-rybelsus--efficacy)

![zepbound appetite changes: man at kitchen counter with small balanced dinner plate](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/zepbound-v2/appetite-cravings-changes.webp)

Smaller portions and fewer food urges are the everyday effect of reduced appetite that this medicine's label describes. Full zepbound appetite changes guide and sources at [healthrx.com/zepbound](https://healthrx.com/zepbound).

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
